Extract from M&A Insights

M&A Insights is our fully-fledged M&A platform for teams operating in the Nordics and DACH countries, enabling clients to identify and qualify opportunities well in advance of any structured process.
Orion to sell diagnostics division to Axcel
April 23, 2018

Orion Group sells its diagnostics division to Axcel, to focus solely on pharmaceuticals. The transaction is valued at 168M EUR and expected to be completed in Q2 2018. Orion states that the diagnostics division has no synergies with its core pharmaceutical business, which is the main rationale for the sale.

ⓘ This story was originally featured in our daily M&A Newsletter - a part of M&A Insights.